Genetic polymorphism of epidermal growth factor 61A>G and cancer risk: A meta-analysis

Cancer Epidemiology

Volumn 34, Issue 2, 2010, Pages 150-156

  Zhang, Yan Mei ^a   Cao, Chao ^b   Liang, Kun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b School of Medicine   (China)

Author keywords

Cancer; EGF; Meta analysis; Polymorphism

Indexed keywords

EPIDERMAL GROWTH FACTOR;

ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CLINICAL TRIAL; COLORECTAL CANCER; EMBASE; ESOPHAGUS CANCER; ETHNICITY; GALLBLADDER CANCER; GENE FREQUENCY; GENETIC POLYMORPHISM; GLIOMA; HUMAN; LUNG CANCER; MEDLINE; MELANOMA; META ANALYSIS; NASOPHARYNX CANCER; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; STOMACH CANCER; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; NEOPLASM;

CASE-CONTROL STUDIES; EPIDERMAL GROWTH FACTOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 77950301325     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2010.02.004     Document Type: Article

References (43)

1. Gleave M.E., Hsieh J.T., Wu H.C., Hong S.J., Zhau H.E., Guthrie P.D., et al. Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma. Cancer Res 53 (1993) 5300-5307
2. Normanno N., Bianco C., De Luca A., and Salomon D.S. The role of EGF-related peptides in tumor growth. Front Biosci 6 (2001) 685-707
3. Salomon D.S., Brandt R., Ciardiello F., and Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19 (1995) 183-232
4. Fisher D.A., and Lakshmanan J. Metabolism and effects of epidermal growth factor and related growth factors in mammals. Endocr Rev 11 (1990) 418-442
5. Groenen L.C., Nice E.C., and Burgess A.W. Structure-function relationships for the EGF/TGF-alpha family of mitogens. Growth Factors 11 (1994) 235-257
6. Jorissen R.N., Walker F., Pouliot N., Garrett T.P., Ward C.W., Burgess A.W., et al. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 284 (2003) 31-53
7. Stoscheck C.M., and King Jr. L.E. Role of epidermal growth factor in carcinogenesis. Cancer Res 46 (1986) 1030-1037
8. Singletary S.E., Baker F.L., Spitzer G., Tucker S.L., Tomasovic B., Brock W.A., et al. Biological effect of epidermal growth factor on the in vitro growth of human tumors. Cancer Res 47 (1987) 403-406
9. Jacobs E.J., Hsing A.W., Bain E.B., Stevens V.L., Wang Y., Chen J., et al. Polymorphisms in angiogenesis-related genes and prostate cancer. Cancer Epidemiol Biomarkers Prev 17 (2008) 972-977
10. Araújo A., Ribeiro R., Azevedo I., Coelho A., Soares M., Sousa B., et al. Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer-a review of the literature. The Oncologist 12 (2007) 201-210
11. Shahbazi M., Pravica V., Nasreen N., Fakhoury H., Fryer A.A., Strange R.C., et al. Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 359 (2002) 397-401
12. McCarron S.L., Bateman A.C., Theaker J.M., and Howell W.M. EGF +61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma. Int J Cancer 107 (2003) 673-675
13. Randerson-Moor J.A., Gaut R., Turner F., Whitaker L., Barrett J.H., Silva Idos S., et al. The relationship between the epidemal growth factor (EGF) 5′UTR variant A61G and melanoma/nevus susceptibility. J Invest Dermatol 123 (2004) 755-759
14. Amend K.L., Elder J.T., Tomsho L., Bonner J.D., Johnson T.M., Schwartz J., et al. EGF gene polymorphism and the risk of incident primary melanoma. Cancer Res 64 (2004) 2668-2672
15. Lanuti M., Liu G., Goodwin J.M., Zhai R., Fuchs B.C., Asomaning K., et al. A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome. Clin Cancer Res 14 (2008) 3216-3222
16. Upadhyay R., Jain M., Kumar S., Ghoshal U.C., and Mittal B. Interaction of EGFR 497Arg > Lys with EGF +61A>G polymorphism: modulation of risk in esophageal cancer. Oncol Res 17 (2008) 167-174
17. Cui L., Pan X.M., Pan C.F., Shang-Guan J., Yu H.B., Chen G.X., et al. Association between epidermal growth factor polymorphism and esophageal squamous cell carcinoma susceptibility. Dig Dis Sci (2009) [Epub ahead of print]
18. Goto Y., Ando T., Goto H., and Hamajima N. No association between EGF gene polymorphism and gastric cancer. Cancer Epidemiol Biomarkers Prev 14 (2005) 2454-2456
19. Hamai Y., Matsumura S., Matsusaki K., Kitadai Y., Yoshida K., Yamaguchi Y., et al. A single nucleotide polymorphism in the 50 untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer. Pathobiology 72 (2005) 133-138
20. Jin G., Miao R., Deng Y., Hu Z., Zhou Y., Tan Y., et al. Variant genotypes and haplotypes of the epidermal growth factor gene promoter are associated with a decreased risk of gastric cancer in a high-risk Chinese population. Cancer Sci 98 (2007) 864-868
21. Bhowmick D.A., Zhuang Z., Wait S.D., and Weil R.J. A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res 64 (2004) 1220-1223
22. Vauleon E., Auger N., Benouaich-Amiel A., Laigle-Donadey F., Kaloshi G., Lejeune J., et al. The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma. Cancer Genet Cytogenet 172 (2007) 33-37
23. Costa B.M., Ferreira P., Costa S., Canedo P., Oliveira P., Silva A., et al. Association between functional EGF 61 polymorphism and glioma risk. Clin Cancer Res 13 (2007) 2621-2626
24. Wang Y., Tian T., Hu Z.B., Tang J., Wang S., Wang X., et al. EGF promoter SNPs, plasma EGF levels and risk of breast cancer in Chinese women. Breast Cancer Res Treat 111 (2008) 321-327
25. Araújo A.P., Ribeiro R., Pinto D., Pereira D., Sousa B., Mauricio J., et al. Epidermal growth factor genetic variation, breast cancer risk, and waiting time to onset of disease. DNA Cell Biol 28 (2009) 265-269
26. Lim Y.J., Kim J.W., Song J.Y., Hong M.S., Jin S.Y., Yoon S.H., et al. Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population. Neurosci Lett 374 (2005) 157-160
27. Kang H.G., Choi J.E., Lee W.K., Kam S., Cha S.I., Kim C.H., et al. +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer. Respirology 12 (2007) 902-905
28. Kang S., Kim J.W., Park N.H., Song Y.S., Park S.Y., Kang S.B., et al. Epidermal growth factor 61A/G polymorphism and uterine cervical cancer. Int J Gynecol Cancer 17 (2007) 492-496
29. Wu G.Y., Hasenberg T., Magdeburg R., Bönninghoff R., Sturm J.W., and Keese M. Association between EGF, TGF-b1, VEGF gene polymorphism and colorectal cancer. World J Surg 33 (2009) 124-129
30. Vishnoi M., Pandey S.N., Modi D.R., Kumar A., and Mittal B. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor B1-1-509C > T gene polymorphisms with gallbladder cancer. Hum Immunol 69 (2008) 360-367
31. Gao L.B., Wei Y.S., Zhou B., Wang Y.Y., Liang W.B., Li C., et al. No association between epidermal growth factor and epidermal growth factor receptor polymorphisms and nasopharyngeal carcinoma. Cancer Genet Cytogenet 185 (2008) 69-73
32. Araújo A.P., Ribeiro R., Pereira D., Pinto D., Sousa B., Catarino R., et al. Ovarian cancer and genetic susceptibility: association of A61G polymorphism in the EGF. Gene Exp Biol Med 234 (2009) 241-245
33. Teixeira A.L., Ribeiro R., Cardoso D., Pinto D., Lobo F., Fraga A., et al. Genetic polymorphism in EGF is associated with prostate cancer aggressiveness and progression-free interval in androgen blockade-treated patients. Clin Cancer Res 14 (2008) 3367-3371
34. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 19 (1955) 251-253
35. Lau J., Ioannidis J.P., and Schmid C.H. Quantitative synthesis in systematic reviews. Ann Intern Med 127 (1997) 820-826
36. Zheng H., Wang Z., Shi X., and Wang Z. XRCC1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis. Lung Cancer 65 (2009) 268-273
37. Higgins J.P., and Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 21 (2002) 1539-1558
38. Higgins J.P., Thompson S.G., Deeks J.J., and Altman D.G. Measuring inconsistency in meta-analyses. BMJ 327 (2003) 557-560
39. Egger M., Smith D.G., Schneider M., and Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
40. Worm M., Makki A., Dippel E., Czarnetzki B.M., and Schadendorf D. Interferon-gamma down regulates epidermal growth factor receptors on human melanoma cells. Exp Dermatol 4 (1995) 305
41. Laurence D.J., and Gusterson B.A. The epidermal growth factor. A review of structural and functional relationships in the normal organism and in cancer cells. Tumor Biol 11 (1990) 229-261
42. Carpenter G., and Cohen S. Epidermal growth factor. J Biol Chem 265 (1990) 7709-7712
43. Trivedi H.S., Moore H., Nasr S., Aggarwal K., Agrawal A., Goel P., et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 93 (2003) 29-34